These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9136827)

  • 1. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease.
    Rugtveit J; Nilsen EM; Bakka A; Carlsen H; Brandtzaeg P; Scott H
    Gastroenterology; 1997 May; 112(5):1493-505. PubMed ID: 9136827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells.
    Rugtveit J; Haraldsen G; Høgåsen AK; Bakka A; Brandtzaeg P; Scott H
    Gut; 1995 Sep; 37(3):367-73. PubMed ID: 7590432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.
    Schreiber S; Heinig T; Thiele HG; Raedler A
    Gastroenterology; 1995 May; 108(5):1434-44. PubMed ID: 7729636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD14(+) macrophages that accumulate in the colon of African AIDS patients express pro-inflammatory cytokines and are responsive to lipopolysaccharide.
    Cassol E; Rossouw T; Malfeld S; Mahasha P; Slavik T; Seebregts C; Bond R; du Plessis J; Janssen C; Roskams T; Nevens F; Alfano M; Poli G; van der Merwe SW
    BMC Infect Dis; 2015 Oct; 15():430. PubMed ID: 26475133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.
    Lissner D; Schumann M; Batra A; Kredel LI; Kühl AA; Erben U; May C; Schulzke JD; Siegmund B
    Inflamm Bowel Dis; 2015 Jun; 21(6):1297-305. PubMed ID: 25901973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease.
    Schreiber S; Heinig T; Panzer U; Reinking R; Bouchard A; Stahl PD; Raedler A
    Gastroenterology; 1995 Jan; 108(1):21-33. PubMed ID: 7806044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease.
    McAlindon ME; Hawkey CJ; Mahida YR
    Gut; 1998 Feb; 42(2):214-9. PubMed ID: 9536946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.
    Atreya R; Zimmer M; Bartsch B; Waldner MJ; Atreya I; Neumann H; Hildner K; Hoffman A; Kiesslich R; Rink AD; Rau TT; Rose-John S; Kessler H; Schmidt J; Neurath MF
    Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the mucosal immune system in inflammatory bowel disease.
    MacDermott RP
    J Gastroenterol; 1996 Dec; 31(6):907-16. PubMed ID: 9027661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.
    Docena G; Rovedatti L; Kruidenier L; Fanning A; Leakey NA; Knowles CH; Lee K; Shanahan F; Nally K; McLean PG; Di Sabatino A; MacDonald TT
    Clin Exp Immunol; 2010 Oct; 162(1):108-15. PubMed ID: 20731675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
    Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
    Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
    Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
    Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
    Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
    J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease.
    Vitale S; Strisciuglio C; Pisapia L; Miele E; Barba P; Vitale A; Cenni S; Bassi V; Maglio M; Del Pozzo G; Troncone R; Staiano A; Gianfrani C
    PLoS One; 2017; 12(8):e0182313. PubMed ID: 28797042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production.
    Liu Z; Geboes K; Colpaert S; D'Haens GR; Rutgeerts P; Ceuppens JL
    J Immunol; 2000 Apr; 164(7):3608-15. PubMed ID: 10725717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
    Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
    Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.
    Panja A; Goldberg S; Eckmann L; Krishen P; Mayer L
    J Immunol; 1998 Oct; 161(7):3675-84. PubMed ID: 9759892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis.
    Bondeson J; Wainwright SD; Lauder S; Amos N; Hughes CE
    Arthritis Res Ther; 2006; 8(6):R187. PubMed ID: 17177994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.
    Kucharzik T; Lügering N; Weigelt H; Adolf M; Domschke W; Stoll R
    Clin Exp Immunol; 1996 Jun; 104(3):483-90. PubMed ID: 9099934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of interleukin-10 or transforming growth factor β signaling in the human colon initiates a T-helper 1 response via distinct pathways.
    Jarry A; Bossard C; Sarrabayrouse G; Mosnier JF; Laboisse CL
    Gastroenterology; 2011 Nov; 141(5):1887-96.e1-2. PubMed ID: 21839042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.